12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Loading...
Loading...

Gainers

  • Regulus Therapeutics RGLS stock moved upwards by 84.8% to $2.55 during Tuesday's pre-market session. The company's market cap stands at $51.5 million.
  • Assure Hldgs IONM stock increased by 73.02% to $0.59. The market value of their outstanding shares is at $3.9 million.
  • Telomir Pharmaceuticals TELO shares increased by 24.89% to $8.58. The market value of their outstanding shares is at $262.6 million.
  • Bioventus BVS shares increased by 16.0% to $6.16. The market value of their outstanding shares is at $387.8 million. The company's, Q4 earnings came out today.
  • Genelux GNLX stock increased by 14.79% to $7.45. The company's market cap stands at $199.0 million.
  • Kineta KA stock moved upwards by 14.37% to $0.79. The company's market cap stands at $8.2 million.

Losers

  • Renalytix RNLX shares fell 27.2% to $0.83 during Tuesday's pre-market session. The market value of their outstanding shares is at $41.4 million.
  • CytomX Therapeutics CTMX stock declined by 17.63% to $2.07. The company's market cap stands at $138.5 million. As per the press release, Q4 earnings came out yesterday.
  • Psyence Biomedical PBM shares fell 17.52% to $1.46. The market value of their outstanding shares is at $19.5 million.
  • ACADIA Pharmaceuticals ACAD stock fell 16.46% to $20.16. The market value of their outstanding shares is at $3.3 billion.
  • NRX Pharmaceuticals NRXP stock declined by 16.3% to $0.56. The market value of their outstanding shares is at $51.3 million.
  • Finch Therapeutics Gr FNCH shares fell 13.7% to $2.95. The company's market cap stands at $4.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: MoversBZI-TFM
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...